Extraprostatic extension into periprostatic fat is a more important determinant of prostate cancer recurrence than an invasive phenotype

Journal of Urology

Volumn 190, Issue 6, 2013, Pages 2061-2067

  Kapoor, Jada ^a,b,c,d   Namdarian, Benjamin ^a,b,c,d   Pedersen, John ^a,b,c,d   Hovens, Chris ^a,b,c,d   Moon, Daniel ^a,b,c,d   Peters, Justin ^a,b,c,d   Costello, Anthony J ^a,b,c,d   Ruljancich, Paul ^a,b,c,d   Corcoran, Niall M ^a,b,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Epworth Prostate Centre Epworth Healthcare   (Australia)

^c Tissupath Pty Ltd   (Australia)

^d B Hill Hospital   (Australia)

Author keywords

Neoplasm invasiveness; Neoplasm recurrence, local; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

FAT;

ADULT; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER RECURRENCE; CANCER RISK; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR INVASION; TUMOR VOLUME;

EID: 84888637888     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.06.050     Document Type: Article

References (23)

1. Ayala AG, Ro JY, Babaian R et al: The prostate capsule: does it exist? Am J Surg Pathol 1989;13:21.
2. Hanahan D and Weinberg R: The hallmarks of cancer. Cell 2000;100:57.
3. Epstein JI, Amin M, Boccon-Gibod L et al: Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005;216:34.
4. Epstein JI, Partin AW, Sauvageot J et al: Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996;20:286.
5. Kattan MW, Wheeler TM and Scardino PT: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499.
6. Hull GW, Rabbani F, Abbas F et al: Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol 2002;167:528.
7. Schröder FH, Hermanek P, Denis L et al: The TNM classification of prostate cancer. Prostate, suppl., 1992;4:129.
8. Tanaka M, Suzuki N, Nakatsu H et al: Significance of capsular attachment and invasion of cancer tissues in prostate cancer. Int J Urol 2003;10:309.
9. Wheeler TM, Dillioglugil O, Kattan MW et al: Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol 1998;29:856.
10. Theiss M, Wirth MP, Manseck A et al: Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 1995;27:13.
11. Sakai I, Harada K, Hara I et al: Prognostic significance of capsular invasion and capsular penetration in Japanese men with prostate cancer undergoing radical retropubic prostatectomy. UroOncology 2004;4:27.
12. Myers RP and Fleming TR: Course of localized adenocarcinoma of the prostate treated by radical prostatectomy. Prostate 1983;4:461.
13. Sherwin JC, Mirmilstein G, Pedersen J et al: Tumour volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. J Urol 2010;183:1808.
14. McNeal JE, Villers AA, Redwine EA et al: Capsular penetration in prostate cancer. Am J Surg Pathol 1990;14:240.
15. Psutka SP, Feldman AS, Rodin D et al: Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension. Urology 2011;78:121.
16. Schiavina R, Borghesi M, Fiorentino M et al: Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score. Int J Urol, Epub ahead of print March 21, 2013.
17. Finley DS, Calvert VS, Inokuchi J et al: Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol 2009;182:1621.
18. Ribeiro R, Monteiro C, Cunha V et al: Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. J Exp Clin Cancer Res 2012;31:32.
19. Ribeiro R, Monteiro C, Silvestre R et al: Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumour stroma. Exp Biol Med 2012;237:1155.
20. Epstein JI, Carmichael MJ, Pizov G et al: Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term follow-up. J Urol 1993;150:135.
21. Magi-Galluzzi C, Evans AJ, Delahunt B et al: International Society or Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working Group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2011;24:26.
22. Jhaveri FM, Zippe CD, Klein EA et al: Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 1999;54:884.
23. Pound CR, Partin AW, Eisenberger MA et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591.